Multisystem inflammatory syndrome in an adult with severe hypoxaemia and thyroiditis responsive to corticosteroid and interleukin 6 inhibitor treatment.
BMJ Case Rep
; 15(5)2022 May 10.
Article
in English
| MEDLINE | ID: covidwho-1832381
ABSTRACT
Multisystem inflammatory syndrome in adults (MIS-A) has been reported as a rare but severe consequence of COVID-19 infection. Adult patients were more likely to present with hypotension and cardiac illness when compared with multisystem inflammatory syndrome in children. Although the exact prevalence of MIS-A is unknown, more cases have been observed in men and younger adults. The pathophysiology of MIS-A is also unclear, but is thought to be caused by a delayed, dysregulated immune response. Given no established guideline for treatment of MIS-A, treatment has been based on case reports. We present a case of MIS-A in a woman in her 60s who had severe hypotension, progressive dyspnoea, massive pleural effusion, hypoxaemia, thyroiditis and multiple organ failure, which dramatically improved after treatment with corticosteroid and interleukin 6 inhibitor.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Thyroiditis
/
COVID-19
/
COVID-19 Drug Treatment
/
Hypotension
Type of study:
Case report
/
Observational study
Topics:
Long Covid
Limits:
Adult
/
Child
/
Female
/
Humans
/
Male
Language:
English
Year:
2022
Document Type:
Article
Affiliation country:
Bcr-2021-248520
Similar
MEDLINE
...
LILACS
LIS